Skip to content

5AM Venture Management, LLC: MLTX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of 5AM Venture Management, LLC on MLTX, newest first. How the timeline and the estimate are built.

5AM Venture Management, LLC held 0 MLTX shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -282,313 shares

    13F-HR 0001799883-25-000002 filed by 5AM Venture Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 282,313 shares
    Change vs previous 13F 0 shares

    5.12% of the 13F portfolio, value $13,325,174.

    13F-HR 0001085146-25-005241 filed by 5AM Venture Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 282,313 shares
    Change vs previous 13F 0 shares

    4.17% of the 13F portfolio, value $11,029,969.

    13F-HR 0001085146-25-003293 filed by 5AM Venture Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 282,313 shares
    Change vs previous 13F 0 shares

    3.65% of the 13F portfolio, value $15,287,249.

    13F-HR 0001085146-25-001687 filed by 5AM Venture Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 282,313 shares
    Change vs previous 13F not available

    2.94% of the 13F portfolio, value $14,234,221.

    13F-HR 0001104659-24-118921 filed by 5AM Venture Management, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).